Results 31 to 40 of about 305,562 (334)
Hepatocellular carcinoma (HCC) is a leading cause of cancer related mortality in the world and it has limited treatment options. Understanding the molecular drivers of HCC is important to develop novel biomarkers and therapeutics.HCC arises in a complex background of chronic hepatitis, fibrosis and liver regeneration which lead to genomic changes. Here,
Nia Adeniji, Renumathy Dhanasekaran
openaire +3 more sources
Breastfeeding as Protective Nutrition: The Immunological Foundation for Infants
Background: Breastfeeding, a crucial foundation for infant health, provides essential protective nutrition and a complex array of immune-protective factors.
Bunga Pelangi +3 more
doaj +1 more source
Rising plasma nociceptin level during development of HCC: A case report [PDF]
AIM: Although liver cirrhosis is a predisposing factor for hepatocellular carcinoma (HCC), relatively few reports are available on HCC in primary biliary cirrhosis.
Folhoffer, Anikó +8 more
core +1 more source
Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway. [PDF]
Tumor recurrence remains an obstacle after liver surgery, especially in living donor liver transplantation (LDLT) for patients with hepatocellular carcinoma (HCC).
Geng, Wei +9 more
core +9 more sources
Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. [PDF]
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and confers a poor prognosis. Beyond standard systemic therapy with multikinase inhibitors, recent studies demonstrate the potential for robust and durable responses ...
Fong, Lawrence +2 more
core +2 more sources
NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
Introduction. Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important and common public health problem that can lead to cirrhosis and hepatic failure (hepatocellular carcinoma – HCC).
D. V. Blinov
doaj +1 more source
Circular RNAs (circRNAs) have previously been confirmed to function as vital regulators in multiple human cancers, including hepatocellular carcinoma (HCC). This study aimed to clarify the role and underlying molecular mechanisms of circ-CFH in HCC. circ-
Chen Zengyin +4 more
doaj +1 more source
An expert consensus for the management of chronic hepatitis B in Asian Americans. [PDF]
BACKGROUND: Hepatitis B virus (HBV) infection is common with major clinical consequences. In Asian Americans, the HBsAg carrier rate ranges from 2% to 16% which approximates the rates from their countries of origin.
Abbas +173 more
core +2 more sources
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source
In the era of transformative technologies, generative artificial intelligence (genAI) offers profound opportunities and challenges for education. This study explores the development and execution of an interactive workshop designed to equip educators ...
Benedikt Brünner +2 more
doaj +1 more source

